Field is a technology company.
Field has raised $14.0M across 1 funding round.
Field has raised $14.0M in total across 1 funding round.
Field has raised $14.0M in total across 1 funding round.
Field's investors include Atomico, Backed VC, BoxOne Ventures, Hoxton Ventures, Mayfield, Olima Ventures, Biz Stone, Charlie Songhurst, Michael Stoppelman, Tania Boler.
Field is a technology company that builds supply‑chain software to increase access to medicines in emerging and frontier markets, primarily by digitizing and simplifying pharmaceutical distribution for clinics, pharmacies, governments and NGOs.【2】【5】
High‑Level Overview
Field develops offline‑capable pharmaceutical supply‑chain and analytics software that helps ensure availability of essential medicines, lower costs, and improve decision‑making for health providers and public systems in frontier and emerging markets.【1】【2】 It serves public health programs, private pharmacies and health systems, and development partners (including donors and NGOs), targeting places where stockouts, expiries and informal distribution meaningfully reduce access to care【1】【5】. Field has shown traction with grant and investor support from development‑oriented backers (for example Bill & Melinda Gates Foundation and Johnson & Johnson Impact Ventures) and has raised roughly $17.6M to date, positioning itself as a specialist technology partner for healthcare supply chains in Africa and other underserved regions【1】.
Origin Story
Field was founded in 2015 and is headquartered in Abuja, Nigeria, with teams across Abuja, Lagos, Nairobi and Berlin【1】【5】. The company was started by multidisciplinary teams of designers, developers, pharmacists and engineers who identified that weak, fragmented supply chains in frontier markets were a major barrier to equitable healthcare access; their product roadmap grew from that operational problem toward digitizing, modernizing and sustaining supply chains for essential medicines【5】. Early validation came from partnerships and grants with development investors and impact‑focused investors that supported pilots and scale efforts in pharmacies and public programs, helping Field evolve from pilot projects to a funded vendor working with governments, providers and donors【1】.
Core Differentiators
Role in the Broader Tech Landscape
Field sits at the intersection of two macro trends: digital transformation of healthcare supply chains and increased donor/private investment in tech solutions for emerging markets. Demand for resilient, data‑driven supply chains is rising because stockouts and expiries drive poor health outcomes and wasted resources; Field’s timing matters because affordable digital tools that work offline are a practical enabler for rapid improvements in those contexts【5】【1】. Market forces in their favor include growing government interest in healthcare digitization, increasing donor funding for systems strengthening, and the maturation of mobile/edge technologies that let software operate reliably where connectivity is poor. By proving operational models that link private pharmacies, clinics and public supply systems, Field can influence procurement practices, data standards and private‑public deployment models across the region【2】【5】.
Quick Take & Future Outlook
What’s next: continued geographic expansion across African markets and deeper integrations with public procurement and donor programs, plus product maturation around predictive analytics, demand forecasting and tighter interoperability with national health information systems—areas that would materially increase Field’s ability to reduce stockouts and expiries【1】【5】. Trends to watch: sustained donor investment in supply‑chain digitalization, governments pushing for national‑level inventory visibility, and competitive pressure from other supply‑chain analytics vendors adapting to low‑resource contexts. If Field continues to execute on deployments and partnerships, it can strengthen its position as a go‑to vendor for pharma logistics in frontier markets and shape how digital supply‑chain tools are procured by ministries and NGOs moving forward【1】【2】【5】.
Quick take: Field addresses a clear, high‑impact gap—making medicine supply chains work where access is hardest—by combining product design for low‑connectivity environments with development‑oriented partnerships; their future influence will depend on scaling government integrations and demonstrating measurable reductions in stockouts, expiries and costs.【5】【1】
Field has raised $14.0M across 1 funding round. Most recently, it raised $14.0M Series A in August 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2021 | $14.0M Series A | Atomico, Backed VC, BoxOne Ventures, Hoxton Ventures, Mayfield, Olima Ventures, Biz Stone, Charlie Songhurst, Michael Stoppelman, Tania Boler |